Prof. David Jayne will present on "A randomized, double-blind, active controlled study of AVACOPAN in anti-neutrophil cytoplasmic antibody-associated vasculitis" in the LBCT Symposium 05 in Room Gold Plenary. Don't miss it! #ERAEDTA20 #ERAEDTA #clinicaltrials

#ERAEDTA2020 #eraedta20 #RITAZERAM trial of maintenance #rituximab vs #azathioprine in #AASV #vasculitis - #RhonaSmith Very clear presentation - steroid tapered and then off. Long follow up off treatment Stephen McAdoo Vasculitis - In memory of John Mills MBE 💙💚 UKIVAS Trinity Kidneys Megan Griffith Versus Arthritis

Ashwasena (अश्‍वसेन) R@gh@v Dr Bhanu Mishra Dr Priti MD,FASN🇮🇳 (प्रिति) Arun Dua

New Review! Plant-based diets to manage the risks & complications of CKD by J Carrero, Ailema González C Avesani, S Bakker, V Bellizzi, Ph.Chauveau, C Clase, A Cupisti, Espinosa con S y CUBREBOCAS 🇲🇽🍒🐝🥂 Pablo Molina, K Moreau, G Piccoli, A Post, S Sezer & @denisfouque1 @eraedta go.nature.com/37lrWXu

NEW DATE! 2020 #EUVAS General Meeting, Salzburg, Austria 2nd November 2020 Details to follow. Please RT.

Sites of actions of HLA class I and II within the immune system in autoimmune and renal disease from our Review by Kate Robson, Kitching Laboratory, Rossjohn lab and colleagues go.nature.com/2GxHVXa

The #lupusnephritis management renaissance doi.org/10.1016/j.kint… Juan Manuel Mejía Ana Malvar Brad H Rovin

Join for upcoming ECNeph session on 25th November , Thursday,9.30PM IST Case scenario of Young man with acute abdomen and AKI Discussant:Dr.Fong Voon Ken Fong Voon Ken Moderator:Dr.Manjusha Yadla manjusha yadla

Dr Emily Shaw I will go with experience

New 'Year in Review' online! Andreas Kronbichler and Rachel Jones look into advances in immune-mediated kidney disease in 2021. go.nature.com/3GVPH9d

The golden age of kidney trials continues! EMPA-KIDNEY stopped early 4 efficacy: amazing collaborators report design & baseline data - watch out for final results late 2022! More hope for patients with #CKD. Christoph Wanner @RichardHaynes3 adeera levin Martin Landray Duke Clinical Research Institute

BIOVAS is an innovative clinical trial, designed here in Cambridge by Pani Gopaluni and Prof David Jayne

One of the pearls presented during #ERA22! An impressive study with a very important message

Rupee at a record low of 79/$, what’s happening? A dummies guide in this 🧵 Do ‘re-tweet’ & help us educate more investors (1/13) #Investing #invest #StockMarket #RupeeVsDollar #RupeeSlideDebate

SGLT2 inhibitors reduce CKD progression by ~40%, regardless of: - Diabetes - CKD aetiology - Type of glomerular disease And reduces AKI by ~20% Presented by Natalie Staplin on behalf of Oxford Population Health (OxPop) Renal Studies Group & SGLT2 Trialists Consortium (SMART-C) #KidneyWk

Congratulations 👏 Dr Pani Gopaluni for the excellent Symposium on transplantation, very insightful on various aspects of kidney transplantation ⁦Hyderabad Nephrology Forum⁩ ⁦Dr Prof Manisha Sahay⁩ ⁦manjusha yadla⁩ ⁦Dr P S Vali⁩ ⁦Srikanth Gundlapalli⁩ ⁦Kiranmai Ismal⁩ ⁦